Evaluation of the new ARCHITECT anti-HCV screening test under routine laboratory conditions

Journal of Clinical Virology

Volumn 43, Issue 2, 2008, Pages 158-161

  Berger, Annemarie ^a   Rabenau, Holger ^a   Allwinn, Regina ^a   Doerr, Hans Wilhelm ^a  

^a GOETHE UNIVERSITY MEDICAL SCHOOL   (Germany)

Author keywords

HCV antibody; Immunoblot; Inno LIA; Ortho; RIBA

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY; RECOMBINANT PROTEIN; VIRUS ANTIBODY; VIRUS PROTEIN;

ARTICLE; BLOOD SAMPLING; CLINICAL EVALUATION; CONTROLLED STUDY; CYTOMEGALOVIRUS; EPSTEIN BARR VIRUS; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HERPES SIMPLEX VIRUS; HUMAN; IMMUNOBLOTTING; LABORATORY TEST; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SCREENING TEST; VARICELLA ZOSTER VIRUS;

CHEMILUMINESCENT MEASUREMENTS; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; IMMUNOASSAY; IMMUNOBLOTTING; MASS SCREENING; PREDICTIVE VALUE OF TESTS; PREGNANCY; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; VIROLOGY;

EID: 50849127822     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2008.05.009     Document Type: Article

References (10)

1. Alter M.J., Kuhnert W.L., and Finelli L. Centers for disease control and prevention. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention. MMWR Recomm Rep 52 (2003) 1-13, 15
2. Jonas G., Pelzer C., Beckert C., Hausmann M., and Kapprell H.P. Performance characteristics of the ARCHITECT anti-HCV assay. J Clin Virol 34 (2005) 97-103
3. Lefrère J.J., Girot R., Lefrère F., Guillaume N., Lerable J., Le Marrec N., et al. Complete or partial seroreversion in immunocompetent individuals after self-limited HCV infection: consequences for transfusion. Transfusion 44 (2004) 343-348
4. Majid A.M., and Gretch D.R. Current and future hepatitis C virus diagnostic testing: problems and advancements. Microbes Infect 4 (2002) 1227-1236
5. Myrmel H., Navaratnam V., and Asjo B. Detection of antibodies to hepatitis C virus: false-negative results in an automated chemiluminescent microparticle immunoassay (ARCHITECT Anti-HCV) compared to a microparticle enzyme immunoassay (AxSYM HCV Version 3.0). J Clin Virol 34 (2005) 211-215
6. Oethinger M., Mayo D.R., Falcone J., Barua P.K., and Griffith B.P. Efficiency of the ortho VITROS assay for detection of hepatitis C virus-specific antibodies increased by elimination of supplemental testing of samples with very low sample-to-cutoff ratios. J Clin Microbiol 43 (2005) 2477-2480
7. Scheiblauer H., El-Nageh M., Nick S., Fields H., Prince A., and Diaz S. Evaluation of the performance of 44 assays used in countries with limited resources for the detection of antibodies to hepatitis C virus. Transfusion 46 (2006) 708-718
8. Semmo N., Barnes E., Taylor C., Kurtz J., Harcourt G., Smith N., et al. T-cell responses and previous exposure to hepatitis C virus in indeterminate blood donors. Lancet 365 (2005) 327-329
9. Watterson J.M., Stallcup P., Escamilla D., Chernay P., Reyes A., and Trevino S.C. Evaluation of the Ortho-Clinical Diagnostics Vitros ECi Anti-HCV test: comparison with three other methods. J Clin Lab Anal 21 (2007) 162-166
10. Zachary P., Ullmann M., Djeddi S., Meyer N., Wendling M.J., Schvoerer E., et al. Evaluation of three commercially available hepatitis C virus antibody detection assays under the conditions of a clinical virology laboratory. J Clin Virol 34 (2005) 207-210